Next Article in Journal
An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation
Next Article in Special Issue
Nucleolin-Targeting AS1411 Aptamer-Conjugated Nanospheres for Targeted Treatment of Glioblastoma
Previous Article in Journal
Questionnaire Study to Investigate the Preferences of Children, Parents, and Healthcare Professionals for Different Formulations of Oral Medicinal Products
Previous Article in Special Issue
Polydopamine-Modified Copper Coordination Mesoporous Silica Nanoparticles Loaded with Disulfiram for Synergistic Chemo-Photothermal Therapy
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(4), 516; https://doi.org/10.3390/pharmaceutics16040516
Action Date Notes Link
article xml file uploaded 8 April 2024 14:06 CEST Original file -
article xml uploaded. 8 April 2024 14:06 CEST Update -
article pdf uploaded. 8 April 2024 14:06 CEST Version of Record https://www.mdpi.com/1999-4923/16/4/516/pdf-vor
article supplementary file uploaded. 8 April 2024 14:06 CEST - https://www.mdpi.com/1999-4923/16/4/516#supplementary
article html file updated 8 April 2024 14:08 CEST Original file -
article xml file uploaded 9 April 2024 04:29 CEST Update -
article xml uploaded. 9 April 2024 04:29 CEST Update -
article pdf uploaded. 9 April 2024 04:29 CEST Updated version of record https://www.mdpi.com/1999-4923/16/4/516/pdf-vor
article html file updated 9 April 2024 04:31 CEST Update -
article xml file uploaded 11 April 2024 05:05 CEST Update -
article xml uploaded. 11 April 2024 05:05 CEST Update https://www.mdpi.com/1999-4923/16/4/516/xml
article pdf uploaded. 11 April 2024 05:05 CEST Updated version of record https://www.mdpi.com/1999-4923/16/4/516/pdf
article html file updated 11 April 2024 05:06 CEST Update https://www.mdpi.com/1999-4923/16/4/516/html
Back to TopTop